Jenburkt Pharmaceuticals Reports Mixed Financial Results for December Quarter 2024

Jan 28 2025 09:30 PM IST
share
Share Via
Jenburkt Pharmaceuticals has announced its financial results for the quarter ending December 2024, showing a decline in its evaluation score. The company achieved a strong Debtors Turnover Ratio of 9.94 times, indicating efficient debt management, while facing a decrease in both Profit After Tax and Profit Before Tax compared to previous averages.
Jenburkt Pharmaceuticals has recently reported its financial results for the quarter ending December 2024. The company, operating within the Pharmaceuticals & Drugs industry, has experienced a notable adjustment in its evaluation, with its score declining to 2 from 11 over the past three months.

In terms of operational efficiency, Jenburkt Pharma has demonstrated a strong Debtors Turnover Ratio, achieving its highest level in the last five half-yearly periods at 9.94 times. This indicates that the company has been effective in settling its debtors more swiftly, which is a positive aspect of its financial management.

Conversely, the financial results reveal challenges for Jenburkt Pharma. The Profit After Tax (PAT) for the quarter stands at Rs 6.51 crore, reflecting a decline of 14.1% compared to the average PAT of the previous four quarters, which was Rs 7.58 crore. Additionally, the Profit Before Tax less Other Income (PBT) has also seen a reduction, recorded at Rs 7.93 crore, down 9.3% from the average PBT of Rs 8.75 crore over the same period.

Overall, these results highlight a mixed performance for Jenburkt Pharmaceuticals, with significant evaluation changes noted in its financial metrics.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News